HEPA
Hepion Pharmaceuticals
HEPA
HEPA
Delisted
HEPA was delisted on the 12th of May, 2025.
43 hedge funds and large institutions have $21.3M invested in Hepion Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 10 increasing their positions, 10 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
43
Holders Change
+5
Holders Change %
+13.16%
% of All Funds
0.75%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
10
Reduced
10
Closed
6
Calls
$1.42M
Puts
$1.38M
Net Calls
+$40K
Net Calls Change
+$91K
Top Buyers
| 1 |
IC
Ikarian Capital
Dallas,
Texas
|
+$2.7M |
| 2 |
Two Sigma Advisers
New York
|
+$1.48M |
| 3 |
ACM
Altium Capital Management
New York
|
+$883K |
| 4 |
State Street
Boston,
Massachusetts
|
+$639K |
| 5 |
Two Sigma Investments
New York
|
+$485K |
